September Deals Simmer On, Ignoring Economic Doom and Gloom
If the healthcare M&A market is the only gauge you use to assess the U.S. economy, you’d be surprised to learn that other countries are entering or bracing for economic slowdowns or outright recession. Monthly deal volumes across all healthcare sectors are holding up fairly well (with the usual ups and downs). Some large national platforms have come on the market (BayMark Health Services being the most recent), stirring up some lively auctions. More are expected in the fourth quarter. September deal volume didn’t surprise. With 130 transactions already on the books, it’s virtually tied with August’s total of 131. Compared with the same month in 2018, deal volume dropped 15% against 153... Read More »
Health Care M&A Deals, Week Ending September 27, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Behavioral Health Care Acquirer Target Price The Stepping Stones Group New England ABA, Inc. N/A Carroll Capital Easy Speech Pathology N/A Golden Gate Capital Invo Holdings, LLC N/A The Family Treatment Network, Inc. Alpine Academy N/A The Family Treatment Network, Inc. Interventions Unlimited N/A... Read More »
Health Care M&A Deals, Week Ending September 20, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price H. Lundbeck A/S Alder BioPharmaceuticals $1,950,000,000 eHealth Acquirer Target Price HMS Holdings Corp. VitreosHealth $36,500,000 Labs, MRI & Dialysis Acquirer Target Price Praesidian Capital Genetics business Long-Term Care... Read More »
Health Care M&A Deals, Week Ending September 13, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Generex Biotechnology Corporation ALTuCELL, Inc. N/A Alexion Pharmaceuticals, Inc. Exclusive license to AG10 $50,000,000 Flexion Therapeutics, Inc. Rights to XEN402 $3,000,000 GlaxoSmithKline plc Sitari Pharmaceuticals N/A eHealth Acquirer Target... Read More »
August Deal Flow Ebbs, as It Follows the Annual Cycle
Enough about slowdowns and recession. August is typically a roller-coaster month in the equity markets and August 2019 didn’t disappoint in that regard. The bond markets’ inverted yield curve persisted into September and that’s never a good sign. We’re moving on. Preliminary data show August’s deal volume wasn’t so bad, considering how most of 2019 has played out. The 125 deals announced in August represent a drop of 8% compared with the previous month’s 136 deals, and a 27% drop compared with August 2018. After a record-setting year in 2018, with more than 1,900 transactions and $333.3 billion on the books, a repeat would be nearly as scary as a sudden downturn (which may be coming,... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
